Method and devices for preventing restenosis after angioplasty

Surgery – Radioactive substance applied to body for therapy – Radioactive substance placed within body

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

600 3, 128657, A61M 3612

Patent

active

052135616

ABSTRACT:
The incidence of restenosis after angioplasty is reduced by exposing the potentially stenotic site to radiation from a source within the same vascular structure in which the site is located. The radioactive source can be mounted at the distal end of a guidewire, or in a balloon catheter, or on a balloon expansible stent, and is inserted through the vascular structure to the site to be exposed.

REFERENCES:
patent: 3674006 (1972-07-01), Holmer
patent: 3866050 (1975-02-01), Whitfield
patent: 4819618 (1989-04-01), Liprie
patent: 4851694 (1989-07-01), Rague et al.
patent: 4963128 (1990-10-01), Daniel et al.
patent: 4976680 (1990-12-01), Hayman et al.
patent: 5059166 (1991-10-01), Fischell et al.
Advanced Cardiovascular Systems, Inc. brochure "Hartzler ACX.TM. Coronary Dilatation Catheter".
Scimed.TM., GSSC 0.018 Skinny.TM. PTCA Dilatation Catheter Instructions for use.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method and devices for preventing restenosis after angioplasty does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and devices for preventing restenosis after angioplasty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and devices for preventing restenosis after angioplasty will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-894351

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.